Immunoassay Analyzers Market Revenue, Trends, Market Share Analysis, and Forecast to 2027

Comments · 16 Views

The Global Immunoassay Analyzers Market is forecasted to grow at a rate of 5.0% from USD 17.75 Billion in 2019 to USD 26.40 Billion in 2027.

The Global Immunoassay Analyzers Market is projected to experience a growth rate of 5.0% from its value of USD 17.75 Billion in 2019 to reach USD 26.40 Billion by 2027. Immunoassay refers to a test that utilizes antibodies or antigens to measure the concentration or presence of a specific molecule. This test detects molecules, also known as analytes or proteins in some cases. Clinical Immunoanalyzers are medical diagnostic devices that employ various immunoassay techniques such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays to identify and quantify specific analytes in blood or body fluid samples. Immunoassay analyzers find applications in the medical field for purposes such as bacteria and viral toxin detection, drug monitoring, allergy testing, and cancer marker identification.

However, the market growth may face obstacles due to stringent policies, regulations, and reduced reimbursements from the public sector in developed markets like the U.S. and Western Europe. The pressure on independent diagnostic laboratories to minimize capital expenditures is another significant restraint for market development. Additionally, the overall business progress may be slowed down by the consolidation process and agreements between hospitals and diagnostic laboratories concerning research and development.

Get a sample of the report @ of Form

Bottom of Form


Companies considered and profiled in this market study

bioMerieux Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Diagnostics, Beckman Coulter Inc., Diasorin S.p.A., Siemens Healthcare GmbHSigma Aldrich. Co. LLC. and Boditech Med, Inc, have been profiled in the report. They are the major manufacturers of the product.

The players operating in the market have undertaken a number of strategies related to the market in the period 2018-2020. The key highlight is:

  • In 2018, in the assay kits sector, Mabtech introduced a human IL3 ELISpot kit. Such advancements continue the growth of the company in the market.
  • To continue its strong presence in the healthcare sector, Lophius Biosciences another product in 2017, the next generation of T Track CMV, an Immune Monitoring Tool. The test is used for risk stratification of human cytomegalovirus in transplant patients.

To know more about the report @

The Immunoassay Analyzers Market is influenced by several driving factors and restraints.

Driving Factors:

  1. Increasing Prevalence of Chronic and Infectious Diseases: The rising incidence of chronic and infectious diseases, such as cancer, cardiovascular diseases, and infectious diseases, is driving the demand for immunoassay analyzers. These devices play a crucial role in the early detection and monitoring of diseases, contributing to their growing adoption.
  2. Technological Advancements: Continuous advancements in immunoassay analyzer technology, including enhanced sensitivity, automation, and multiplexing capabilities, are fueling market growth. These technological developments enable faster and more accurate analysis of samples, leading to improved diagnostic outcomes.
  3. Growing Demand for Point-of-Care Testing: The increasing preference for point-of-care testing, which allows for rapid on-site diagnosis and treatment decisions, is driving the demand for immunoassay analyzers. These analyzers provide quick results, enabling timely interventions and improved patient care in various healthcare settings.
  4. Increasing Focus on Personalized Medicine: The shift towards personalized medicine, which aims to provide tailored treatments based on individual patient characteristics, is boosting the demand for immunoassay analyzers. These devices facilitate the measurement of specific biomarkers and assist in selecting appropriate therapies and monitoring treatment responses.


  1. Stringent Regulations and Reimbursement Policies: The immunoassay analyzers market faces challenges due to strict regulations and reimbursement policies imposed by regulatory authorities and public healthcare systems. These regulations and policies can increase the complexity and cost of market entry, impacting the growth prospects for market players.
  2. High Cost of Immunoassay Analyzers: The high upfront cost associated with immunoassay analyzers, including instrument purchase, maintenance, and consumables, can hinder their widespread adoption. The affordability of these devices remains a concern, especially in developing regions with limited healthcare budgets.
  3. Limitations of Immunoassay Techniques: While immunoassay analyzers offer several advantages, they also have certain limitations. These techniques may face challenges in terms of sensitivity, specificity, and interference from matrix effects, leading to potential false-positive or false-negative results. Overcoming these limitations and ensuring the accuracy of immunoassay tests is crucial for market growth.
  4. Consolidation in the Healthcare Industry: The ongoing consolidation process in the healthcare industry, such as mergers and acquisitions between hospitals, diagnostic laboratories, and healthcare organizations, can slow down the overall business growth of immunoassay analyzers. Such consolidation activities may result in changes in purchasing patterns and supplier relationships, affecting market dynamics.

Request a customization of the report @

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370


Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @

Browse More Reports:

Ambulatory Surgery Centers (ASCs) Market

Tissue Ablation Products Market

Closed MRI Systems Market

Ophthalmic Ultrasound Devices Market

Preparative and Process Chromatography Market


Read more